CompletedNot Applicable

Gut Microbiota in Acute Stroke Patients

Hong Kong120 participantsStarted 2018-07-01

Plain-language summary

This study is to find out the significance of gut-microbiota in acute stroke patients, including their neurological, radiological outcomes as well as their stroke mechanisms.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosed as acute ischaemic stroke
✓. Aged 18 or above Chinese
✓. Radiological evidence of acute ischaemic stroke by Computed tomography (CT) or magnetic resonance imaging (MRI) brain.

Exclusion criteria

✕. Patient with symptoms and signs suggestive of alternative diagnoses,
✕. Evidence of intracerebral haemorrhage,
✕. Absence of DWI evidence of acute ischaemic infarct,
✕. Pregnancy,
✕. Evidence of gastrointestinal infection/ inflammation/ obstruction
✕. History of partial or total resection of small or large bowel, as well as gut re-anastomosis,
✕. Use of antibiotics within 2 weeks prior to symptoms onset,
✕. Gastrointestinal malignancy

What they're measuring

The composition of gut-microbiota contributing neurological outcome between groups

Timeframe: 31 Dec, 2020

Trial details

NCT IDNCT03934021

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08-30

View on ClinicalTrials.gov More Stroke trials